Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure (Q35001643)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure |
scientific article |
Statements
1 reference
Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure (English)
1 reference
Patrick Schöffski
1 reference
Jaap Verweij
1 reference
Samuel E Deprimo
1 reference
Xin Huang
1 reference
Martin E Blackstein
1 reference
Christopher R Garrett
1 reference
Charles S Harmon
1 reference
Manisha H Shah
1 reference
Charles M Baum
1 reference
George D Demetri
1 reference
8 September 2009
1 reference
1 reference
15
1 reference
18
1 reference
5869-5877
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference